Heart blood vessel effects of immunotherapy in breast and lung cancer
Part of Cancer, Heart & circulation, Injuries & trauma, Lungs & breathing, Skin clinical trials.
This trial studies whether immunotherapy drugs (called immune checkpoint inhibitors) affect the small blood vessels of the heart. If you have breast cancer or lung cancer and are starting a specific treatment plan, you may be asked to have a special heart scan before and during therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have either breast cancer treated with the Keynote 522 plan, or non-small-cell lung cancer that will be treated with pembrolizumab before surgery.
- You have not had immunotherapy (immune checkpoint inhibitors) before.
- You are not pregnant or breastfeeding.
- You do not have any medical condition that would make a heart PET/CT scan unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches how chemotherapy and HER2-targeted drugs affect your heart during early-stage breast cancer treatment. Researchers use heart scans to catch any changes early and understand how to protect heart health.
This trial tests whether common heart medicines (statins or ACE-inhibitors) can protect the heart during cancer radiation therapy. It is for adults who are about to start chest radiation and have not taken these drugs before.
This study looks at whether PET-CT scans can help detect heart damage caused by radiation therapy in patients with stage III lung cancer. If you're getting chemotherapy and radiation together, you may participate to help doctors find ways to reduce heart risks.
This trial looks at whether immunotherapy drugs (checkpoint inhibitors) cause heart problems in people with certain cancers. It will help doctors understand who is at risk and how to monitor for side effects.
This study looks at how immune checkpoint inhibitors—medicines that help your body fight cancer—might affect your blood vessels and circulation. By joining, you'll help doctors understand and better manage these potential side effects.
This study looks at whether certain immunotherapy drugs (nivolumab, pembrolizumab, or ipilimumab) affect the heart in people with skin cancer. You will have special heart imaging to check for any early signs of heart problems.
Hear when a new Coronary Microvascular Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.